NeoVac
Biotechnology Research
Milton Park, United Kingdom
26 employees
- Employees
- 26
- Contacts
- 1
- Emails
- 1
- Phones
- 1
NeoVac Overview
- Headquarters
- Milton Park, United Kingdom
- Website
- www.neovac.co.uk
- Industry
- Biotechnology Research
- Employees
- 26
- Founded
- 2021
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About NeoVac
NeoVac is a clinical-stage company creating a revolutionary, unique and proprietary next-generation lipid nanoparticles platform to enable better RNA vaccines and medicines for various diseases. Allowing more people around the world access to better and more potent vaccines, using cutting-edge technology that makes RNA vaccines more transportable, with broader capabilities and fewer side effects.
NeoVac Contact Details
- People in AeroLeads
- 4
- With contact data
- 1
- Email contacts
- 1
- 25.0% coverage
- Phone contacts
- 1
- 25.0% coverage
NeoVac Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Heinrich Haas | Rna and Drug Delivery, Pharmaceutical Technology | Frankfurt Rhine-main Metropolitan Area, Germany |
Email
Phone
|
| Eran Eilat | Senior Advisor and Co-founder Neovac Ltd |
View
|
|
| Jan Hendrik Egberts | CEO at Neovac & Managing Director at Veritas Investments |
View
|
|
| Ramishetti Srinivas | VP of Technology |
View
|
Employees by Management Level
Executive
2 profiles
VP / Head
1 profile
Individual contributor
1 profile
Compare Similar Companies to NeoVac
OXB
Pharmaceutical Manufacturing
Immunocore
Biotechnology Research
Ramot - Tel Aviv University's Tech Transfer Company
Research Services
NanoVation Therapeutics™
Biotechnology Research
Arctoris
Biotechnology Research
GENinCode Predictive Genetics
Biotechnology Research
Akamis Bio
Biotechnology Research
European Vaccine Initiative (EVI)
Non-Profit Organizations
Vaccine Formulation Institute
Non-Profit Organizations
SpyBiotech
Biotechnology Research